Process development of key intermediates is always conducted in a patent non-infringing manner. Because ScinoPharm's customers are European and Northern American-based, it is essential that we fully adhere to IP issues.

After conducting a preliminary patent search and developing a process route, we supply the detailed experimental data to our patent department in ScinoPharm Taiwan so they can conduct a full IP search to ensure that there is no patent infringement.